GM1 ganglioside could be the best thing since levodopa for PD patients! It really is so strange why there isn't more national news about the successful results of this phase II trial.

Is there even going to be a phase III trial? How can PD patients like ourselves make a difference into getting this treatment into further trials and expedited approvals? Is there an expedited FDA review process for such groundbreaking treatments like this? I read there's concern about the product being derived from cow and sheep brains and also some patent issues with the Italian manufacturer, but there must be a way to help this process along.

The researcher Jay Schneider is now studying sialidases as a way to boost endogenous levels of GM1. He has a grant funded from the MJF Foundation. But this research could take a decade. So why not get GM1 safety issues sorted out now to help PD patients now while in parallel working on sialidases and other related research?